Log in or Sign up for Free to view tailored content for your specialty!
Cirrhosis/Liver Failure News
BLOG: Predicting sinusoidal obstructive syndrome after allogeneic stem cell transplantation
Sinusoidal obstructive syndrome is a rare but potentially serious complication that can occur after hematopoietic stem cell transplantation.
VIDEO: Women, Black patients underrepresented in US-based clinical trials for LT
WASHINGTON — In a Healio video exclusive, Saqr Alsakarneh, MD, MSc, describes “significant disparities” in race, ethnicity and sex among participants enrolled clinical trials for liver transplantation in the U.S.
Log in or Sign up for Free to view tailored content for your specialty!
Low bone mineral density score may predict risk for liver cirrhosis
Low bone mineral density may be a risk factor for developing cirrhosis, according to study findings published in The Journal of Clinical Endocrinology & Metabolism.
Nearly 90% of liver transplant center websites still use alcohol-stigmatizing language
A “vast majority” of liver transplant centers use stigmatizing language, such as “alcoholic” or “alcohol abuse,” when describing patients with alcohol use disorder and alcohol-associated liver disease on their websites, researchers reported.
Threefold higher rate of cirrhosis, HCC linked to alcohol overconsumption in MASLD
Around 17% of patients with metabolic dysfunction-associated steatotic liver disease have or will be diagnosed with alcohol-related disease, which research shows is associated with a threefold higher rate of developing cirrhosis or cancer.
VIDEO: GIs will need to become ‘better at hepatology’ ahead of looming workforce shortage
In a Healio video exclusive, Edward V. Loftus Jr., MD, urged gastroenterologists to familiarize themselves with a “four-pronged approach to liver disease” ahead of the critical shortage of U.S. hepatologists expected by 2033.
Up to 10% of veterans with dementia have FIB-4 scores that suggest undiagnosed cirrhosis
Physicians treating older veterans with dementia “should consider underlying cirrhosis” and use Fibrosis-4 as a screening tool to uncover reversible factors, such as hepatic encephalopathy, that may be associated with cognitive decline.
Q&A: ADVANCE trial could generate ‘multiple therapeutic targets’ for cirrhosis
A $37 million study led by Newcastle University, University of Edinburgh and Boehringer Ingelheim is underway to address the “urgent need” for anti-scarring therapies for individuals with liver disease.
Use of beta-blockers linked to acute kidney injury, mortality in decompensated cirrhosis
Use of nonselective beta-blockers was associated with stage 2 acute kidney injury and all-cause mortality among patients with decompensated cirrhosis waitlisted for liver transplantation, data showed.
Dry January campaign aims to make ‘first step’ toward abstinence less daunting
Each January, Alcohol Change UK runs Dry January, a post-holiday campaign that encourages people to abstain from alcohol for 31 days at the beginning of the year and drink more healthily year-round.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read